Related Experiment Video
Updated: Aug 17, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Pathogenic mechanisms in membranoproliferative glomerulonephritis
Kelly D Smith1, Charles E Alpers
1Department of Pathology, University of Washington, Seattle, WA 98195, USA.
Purpose Of Review:
This review considers new information on the pathogenesis of a long recognized and poorly understood form of glomerular injury, membranoproliferative glomerulonephritis. This disease has received growing attention as it is the principal renal manifestation of hepatitis C virus infection, which has become pandemic worldwide.
Recent Findings:
This review briefly describes three murine models of membranoproliferative glomerulonephritis suitable for pathogenesis studies. We consider recent evidence implicating innate immune mechanisms in immune and autoimmune-mediated glomerulonephritis, and recent data pointing to the alternative pathway of complement activation in the amplification of glomerulonephritic injury.
Summary:
Understanding the contribution of complement activation and innate immunity to the evolution of membranoproliferative glomerulonephritis promises to provide new therapeutic targets for this disease. Inhibitors of the complement cascade are already being tested in clinical trials as therapeutic interventions for some human glomerular diseases. Successful tests of this approach in membranoproliferative glomerulonephritis are still awaited. Our understanding of how the innate immune system modulates glomerulonephritis is still in an early stage, and future studies should be directed at identifying targets and specific interventions that may also benefit patients with this disease.
Insights
This review explores the pathogenesis of membranoproliferative glomerulonephritis (MPGN), a kidney disease linked to hepatitis C virus infection. New findings highlight the roles of innate immunity and complement activation in MPGN progression, suggesting potential therapeutic targets.
Area of Science:
- Nephrology
- Immunology
- Virology
Background:
- Membranoproliferative glomerulonephritis (MPGN) is a poorly understood glomerular injury.
- MPGN is the primary renal manifestation of hepatitis C virus (HCV) infection, a global pandemic.
- Growing attention is focused on understanding MPGN pathogenesis due to its association with HCV.
Purpose of the Study:
- To review new information on the pathogenesis of MPGN.
- To discuss the role of innate immunity and complement activation in MPGN.
- To identify potential therapeutic targets for MPGN.
Main Methods:
- Review of recent scientific literature.
- Description of murine models for MPGN pathogenesis studies.
- Analysis of evidence implicating innate immune mechanisms and complement activation.
Main Results:
- Recent evidence suggests innate immune mechanisms contribute to immune- and autoimmune-mediated glomerulonephritis.
- The alternative pathway of complement activation plays a role in amplifying glomerulonephritic injury.
- Murine models of MPGN are available for pathogenesis research.
Conclusions:
- Understanding complement activation and innate immunity in MPGN pathogenesis can lead to new therapeutic targets.
- Complement cascade inhibitors are under clinical investigation for glomerular diseases.
- Further research is needed to identify specific innate immune targets for MPGN treatment.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Streptococcal Pharyngitis
Encephalitis ll: Pathophysiology
Acute Kidney Injury II: Pathophysiology
Determinants of Bacterial Pathogenicity and Virulence
Diabetic Nephropathy

